Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Total 13F shares
-
108,476,937
-
Share change
-
+11,006,649
-
Total reported value
-
$2,407,193,089
-
Put/Call ratio
-
26%
-
Price per share
-
$22.19
-
Number of holders
-
162
-
Value change
-
+$282,716,887
-
Number of buys
-
89
-
Number of sells
-
80
Institutional Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q3 2018
As of 30 Sep 2018,
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,476,937 shares.
The largest 10 holders included
Fosun International Ltd, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Vanguard Group Inc, BlackRock Inc., TPG Group Holdings (SBS) Advisors, Inc., FRONTIER CAPITAL MANAGEMENT CO LLC, JANUS HENDERSON GROUP PLC, and BRIDGER MANAGEMENT, LLC.
This page lists
162
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.